Current radioisotopes and radiopharmaceuticals for radiosynoviorthesis: basic and applied characteristics, production and availability.
Q J Nucl Med Mol Imaging
; 66(4): 304-310, 2022 Dec.
Article
en En
| MEDLINE
| ID: mdl-36377613
ABSTRACT
This overview describes the basic characteristics and chemistry, production and the clinical applications and use of radiopharmaceuticals pertaining to radiosynoviorthesis (RSO). In each of the case scenarios, the physical and clinical parameters that serve as determinants and govern the choice of a particular radionuclide employed for RSO are discussed. References have been drawn on the fundamentals of RSO where applicable, including a brief review of the principles and mechanism of action, the indication and efficacy of RSO in different disease conditions and suggestions set out by the current guideline recommendations.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Radioisótopos
/
Radiofármacos
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Año:
2022
Tipo del documento:
Article